跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MF59 Adjuvant
首页
药物
MF59 Adjuvant
MF59 Adjuvant
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR IMPROVING IMMUNOGENICITY BY USING GLYCO-CORONAVIRUS RBD ANTIGEN CONJUGATE
WO 2022053016 A1
申请人: SINOCELLTECH LTD
优先权: 2020
CN
WO
2 件公开
ADJUVANT COMPOSITIONS
US 2009047306 A1
申请人: M N L PHARMA LTD
优先权: 2004
US
Triple inactivated vaccine against dairy cattle mastitis and preparation method thereof
CN 101991847 A
申请人: CHIFENG BOEN PHARMACEUTICAL CO LTD
优先权: 2010
CN
Bovine staphylococcus aureus mastitis inactivated vaccine and preparation method thereof
CN 101979089 A
申请人: CHIFENG BOEN PHARMACEUTICAL CO LTD
优先权: 2010
CN
Preparation process of avian influenza virus split vaccine containing MF59 adjuvant
CN 102600468 A
申请人: ZHEJIANG TIANYUAN BIOLOG PHARMACEUTICAL CO LTD
优先权: 2012
CN
Application of CpG composite adjuvant in MUC1 fusion protein tumor resistance
CN 107158375 A
申请人: TAI GUIXIANG
优先权: 2017
CN
Preparation method of adsorbed diphtheria, tetanus and acellular pertussis and hemophilus influenza type B tetravalent combined vaccine
CN 107970442 A
申请人: CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD
优先权: 2017
CN
Concentrated oil-in-water submicron emulsion adjuvant and preparation method thereof
CN 113876943 A
申请人: SINOCELLTECH LTD
优先权: 2020
CN
Influenza-neoxanthoceras sorbifolia unit mixed vaccine as well as preparation method and application thereof
CN 116763913 A
申请人: UNIV ZHEJIANG CITY COLLEGE
优先权: 2023
CN
Preparation method of MF59 adjuvant
CN 118681008 A
申请人: ANHUI RUIBAI PHARMACEUTICAL CO LTD
优先权: 2024
CN
第 1 / 3 页
上一页
下一页
药物
反馈